Jerome Ritz, MD, Hematology, Boston, MA, Brigham and Women's Hospital

JeromeRitzMD

Hematology Boston, MA

Hematologic Oncology

Professor of Medicine, Dana-Farber Cancer Institute

Dr. Ritz is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ritz's full profile

Already have an account?

  • Office

    450 Brookline Ave
    M530, Dana-Farber Cancer Institute
    Boston, MA 02215
    Phone(617) 632-3465
    Fax(617) 632-5167
  • Is this information wrong?

Summary

  • Dr. Jerome Ritz is a hematologist in Boston, MA and is affiliated with multiple hospitals in the area, including Brigham and Women's Hospital and Dana-Farber Cancer Institute. He is Professor of Medicine at Harvard Medical School. He received his medical degree from Chicago Medical School at Rosalind Franklin University and has been in practice 45 years. He specializes in hematologic oncology and is experienced in hematologic oncology, hematopoietic stem cell transplantation and cellular therapies.

Education & Training

  • University of Wisconsin
    University of WisconsinRESIDENCY
  • Chicago Medical School at Rosalind Franklin University
    Chicago Medical School at Rosalind Franklin UniversityMEDICAL_SCHOOL

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1976 - 2021
  • CO State Medical License
    CO State Medical License 1975 - 1980
  • WI State Medical License
    WI State Medical License 1973 - 1979
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1990
  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Abstracts/Posters

  • Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Na¥ve Patients with Relapsed or Refractory My...
    Jerome Ritz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Improved Outcomes with Cyclophosphamide/Total Body Irradiation 14 Gy Compared to Cyclophosphamide/Total Body Irradiation 12 Gy in Patients with Acute Lymphoblastic Leu...
    Jerome Ritz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Development of HHV-6-Specific Immunity after Cord Blood Transplantation in Adults Depends on Reconstitution of Thymopoiesis and Regeneration of CD4+ T Cells
    Jerome Ritz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • PD-1 Blockade with Pembrolizumab for Classical Hodgkin Lymphoma after Autologous Stem Cell Transplantation 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Dana-Farber Collaborates with Mass. Eye and Ear to Rebuild Damaged Corneas Using Patients’ Own Stem Cells for First Time in United States
    Dana-Farber Collaborates with Mass. Eye and Ear to Rebuild Damaged Corneas Using Patients’ Own Stem Cells for First Time in United StatesSeptember 01, 2020
  • Local Doctors, Researchers Make Break Through in Treating Corneal Blindness
    Local Doctors, Researchers Make Break Through in Treating Corneal BlindnessSeptember 01, 2020
  • Equillium to Present Translational Data on Itolizumab for Acute Graft-Versus-Host Disease at 61st American Society of Hematology (ASH) Annual Meeting and Exposition
    Equillium to Present Translational Data on Itolizumab for Acute Graft-Versus-Host Disease at 61st American Society of Hematology (ASH) Annual Meeting and ExpositionNovember 26, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations